Retainer ring = black.Customer returned insulin pump for alleged prime/fill anomaly, no communication between pump and transmitter and high bg found on (b)(6)2022.Device passed displacement test, self test, rewind test, prime/seating test, basic occlusion test, force sensor test and occlusion test.No unexpected alarms noted during testing.Device successfully downloaded traces and history files using thus.No prime anomaly noted during test.Device properly paired guardian link 3 transmitter.No communication anomaly noted.The electronic assemblies and motor assemblies were inspected, and no anomalies noted.Motor was tested outside of the device and passed the ngp system board test.Force sensor was measured and is within spec (23.3mv at zero offset).Test p-cap / reservoir locks properly into place.No cosmetic damage was found during visual inspection.No communication between pump and transmitter not confirmed during testing.No communication between pump and transmitter not confirmed during testing.Unable to confirm the customer allegation on the high bg.This mdr related to the puerto rico manufacturing site has been assigned a medwatch number from the medtronic minimed northridge site, per variance 5.Medtronic, inc.(medtronic) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information in the time allotted and has provided as much information as is available to the company as of the submission date this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects" or has "malfunctioned".These words are included in the fda 3500a form and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.Medtronic objects to the use of these words and others like it because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|